QT Imaging Holdings Announces Partnership with Premier Cancer Center, The Vincere Cancer Center in Scottsdale, AZ
QT Imaging Holdings, Inc. (NASDAQ:QTI) partners with The Vincere Cancer Center in Scottsdale, AZ, renowned for cancer prevention, early detection, and innovative cancer services. The center's founders, Dr. Shukla and Dr. Prichard, focus on superior cancer care with precision technology. The partnership aims to redefine standards of care in breast cancer detection, offering accessible and accurate screening solutions.
Partnership with a top cancer center, enhancing credibility and access to a wider patient base.
Focus on innovative precision technology to improve cancer prevention and early detection.
Expansion of medical imaging access and superior patient experience.
Swift commercialization plan post-public listing, indicating growth opportunities.
Potential challenges in ensuring widespread adoption of the new imaging technology.
Risk of market competition in the medical device industry affecting revenue.
The Vincere Cancer Center is a top cancer center in the
“In recent years, there has been an increased rate of breast cancer incidents, especially amongst women younger than 40, the recommended age of initial mammogram screening,” said Dr. Shukla, Director of The Vincere Cancer Center. “Despite this, there has been very little technological advancement in detection of breast cancer that is suitable and accessible to all women. By harnessing the power of the QT Imaging Breast Acoustic CT™ Scanner and eliminating the discomfort associated with traditional methods, our partnership with QT Imaging is redefining standards of care and empowering patients with precision and safety.”
“The QT Imaging team’s mission is to expand access to medical imaging while ensuring superior patient experience, lowering costs for providers, and improving health outcomes,” said Dr. Raluca Dinu, Chief Executive Officer. “We are incredibly excited about the opportunity to work with such a prestigious cancer center and to be able to provide women a choice in their care that is safe and doesn’t jeopardize accuracy or accessibility. The partnership with Vincere Cancer Center represents the continuation of our swift commercialization plan since the company went public two months ago.”
About QT Holding, Inc.
QT Imaging Holdings, Inc. is a public (NASDAQ: QTI) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging, please visit the company’s website at www.qtimaging.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as "will," and "expect," or the negative thereof or comparable terminology, and include (without limitation) statements regarding the partnership between QT Imaging and The Vincere Cancer Center, the QT Imaging Breast Acoustic CTTM Scanner, plans for QT Imaging, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: the ability of the parties to sell and deploy the QT Imaging Breast Acoustic CTTM Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and "bring to market" plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging’s (and its predecessor, GigCapital5, Inc.) filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging as of the date hereof, and QT Imaging assumes no obligation to update any forward-looking statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240508165692/en/
For media inquiries:
Susan Schaffler
Head of Communications
Susan.Schaffler@qtimaging.com
Stas Budagov
Chief Financial Officer
Stas.Budagov@qtimaging.com
Source: QT Imaging Holdings, Inc.
FAQ
<p>What is the partnership between QT Imaging Holdings and The Vincere Cancer Center about?</p>
The partnership aims to provide innovative body imaging systems for cancer prevention, early detection, and comprehensive cancer services at The Vincere Cancer Center in Scottsdale, AZ.
<p>Who are the founders of The Vincere Cancer Center?</p>
The center was founded by Dr. Vershalee Shukla and Dr. Pablo Prichard.
<p>What technology is being utilized for breast cancer screening at The Vincere Cancer Center?</p>
The QT Imaging Breast Acoustic CT™ Scanner is being used for breast cancer screening at the center.
<p>How does the partnership between QT Imaging and The Vincere Cancer Center benefit patients?</p>
The partnership offers patients a choice in care that is safe, accurate, and accessible, redefining standards of care in breast cancer detection.
<p>What is the mission of the QT Imaging team?</p>
The mission is to expand access to medical imaging, ensure superior patient experience, lower costs for providers, and improve health outcomes.
